Research Article
Protein Expression of TLR2, TLR4, and TLR9 on Monocytes in TB, HIV, and TB/HIV
Table 1
Study participants demographic and clinical characteristics.
| Variables | HC (n = 39) | HIV (n = 35) | TB (n = 34) | TB/HIV (n = 12) |
| Age in years, median | 28 | 33 | 30 | 41 | Male sex at birth (%) | 58.3 | 42.4 | 69.2 | 50 | Body mass index | 21.9 | 20.6 | 18.3 | 19.6 | BCG scar present (%) | 42 | 20 | 40 | 42 | PTB (%) | N/A | N/A | 89 | 70 | HIV clinical stages I and II (%) | N/A | 83.3 | N/A | 0 | HIV viral load, median (IQR) | N/A | 5.3 × 104 (1–18 × 104) | N/A | 3.6 × 105 (LDL#−2 × 106) | Absolute CD4, median (IQR) | N/A | 270 (94–599) | N/A | 210 (85–289) | CCL2ǂ | 129 | 148 | 114 | 136 | CCL3 | UD | UD | 135 | UD | CCL4 | UD | UD | 138 | 79 | CXCL10 (IP10) | 39 | 107 | 234 | 125 | TNFα | 1.2 | 2.4 | 2.7 | 2.4 | IFNγ | UD | 2.75 | 12.5 | 3.69 | IL6 | 0.69 | 0.53 | 7.66 | 2.45 | IL10 | 1.6 | 6.14 | 19.1 | 7.37 |
|
|
ǂPlasma biomarkers in ug/ml and UD, undetectable, #48 copies/ml, sample size of 24, and sample size of 7. |